Inhibition of TGF-β modulates macrophages and vessel maturation in parallel to a lowering of interstitial fluid pressure in experimental carcinoma
Open Access
- 1 April 2005
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 85 (4) , 512-521
- https://doi.org/10.1038/labinvest.3700252
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- High interstitial fluid pressure — an obstacle in cancer therapyNature Reviews Cancer, 2004
- Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancerNature Medicine, 2004
- The two faces of transforming growth factor β in carcinogenesisProceedings of the National Academy of Sciences, 2003
- Interference with TGF‐β1 and ‐β3 in tumor stroma lowers tumor interstitial fluid pressure independently of growth in experimental carcinomaInternational Journal of Cancer, 2002
- Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastasesJournal of Clinical Investigation, 2002
- Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effectsJournal of Clinical Investigation, 2002
- Lowering of tumoral interstitial fluid pressure by prostaglandin E1 is paralleled by an increased uptake of51Cr-EDTAInternational Journal of Cancer, 2000
- Soluble Transforming Growth Factor-β Type II Receptor Inhibits Negative Remodeling, Fibroblast Transdifferentiation, and Intimal Lesion Formation But Not Endothelial GrowthCirculation Research, 1999
- Interstitial fluid pressure in DMBA-induced rat mammary tumoursScandinavian Journal of Clinical and Laboratory Investigation, 1982
- Purification of Mouse Immunoglobulin Heavy‐Chain Messenger RNAs from Total Myeloma Tumor RNAEuropean Journal of Biochemistry, 1980